Island Pharmaceuticals Seeks ASX Quotation for 690,000 New Shares Following Option Conversion
Island Pharmaceuticals applied for quotation of 690,000 new fully paid ordinary shares on the ASX following the exercise of existing options. The shares were issued at $0.21 each, representing a modest increase in the company’s total share capital rather than a new fundraising effort. The company confirmed it remains compliant with disclosure requirements and that no additional material information has been withheld from the market. 
Island Pharmaceuticals Seeks ASX Quotation for 690,000 New Shares Following Option Conversion